Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-13
DOI
10.1007/s00262-021-03053-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum
- (2020) Divyanshu Dubey et al. ANNALS OF NEUROLOGY
- Encephalitis as an immune-related adverse event
- (2020) Shigeaki Suzuki JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Central nervous system complications associated with immune checkpoint inhibitors
- (2020) Alberto Vogrig et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature
- (2020) Kensuke Okada et al. JOURNAL OF NEUROLOGY
- HLA‐B27 association of autoimmune encephalitis induced by PD‐L1 inhibitor
- (2020) Hyeyeon Chang et al. Annals of Clinical and Translational Neurology
- Cranial Nerve Disorders Associated with Immune Checkpoint Inhibitors
- (2020) Alberto Vogrig et al. NEUROLOGY
- Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors
- (2020) Jeffrey Aldrich et al. Arthritis & Rheumatology
- Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review
- (2019) Hiroko Kadota et al. Current Rheumatology Reports
- Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies
- (2019) Annette Johansen et al. NEUROLOGY
- Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors
- (2019) Francesc Graus et al. Nature Reviews Clinical Oncology
- Inflammatory myopathy associated with PD-1 inhibitors
- (2019) Morinobu Seki et al. JOURNAL OF AUTOIMMUNITY
- Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
- (2019) Douglas B. Johnson et al. Journal for ImmunoTherapy of Cancer
- A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis
- (2019) Douglas B. Johnson et al. NATURE MEDICINE
- Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
- (2019) Audrey Simonaggio et al. JAMA Oncology
- Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies
- (2019) Divyanshu Dubey et al. NEUROLOGY
- Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors
- (2019) Shiro Matsubara et al. Journal for ImmunoTherapy of Cancer
- Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
- (2019) Alberto Vogrig et al. Neurology-Neuroimmunology & Neuroinflammation
- Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
- (2019) Houssein Safa et al. Journal for ImmunoTherapy of Cancer
- Drug-induced aseptic meningitis: a mini-review
- (2018) Melissa Yelehe-Okouma et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Relapsed Myasthenia Gravis after Nivolumab Treatment
- (2018) Ayumi Mitsune et al. INTERNAL MEDICINE
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Inhibitor-associated Myopathies
- (2018) Teerin Liewluck et al. JOURNAL OF IMMUNOTHERAPY
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer
- (2018) Koji Haratani et al. JAMA Oncology
- Immune Checkpoint Inhibitor–Associated Myositis
- (2018) Céline Anquetil et al. CIRCULATION
- Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer
- (2018) Mehdi Touat et al. NEUROLOGY
- Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia
- (2018) Koutaro Takamatsu et al. Annals of Clinical and Translational Neurology
- Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
- (2017) S. Cuzzubbo et al. EUROPEAN JOURNAL OF CANCER
- Acute demyelinating polyneuropathy induced by nivolumab
- (2017) Yuta Fukumoto et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan
- (2017) Shigeaki Suzuki et al. NEUROLOGY
- Neurological Complications Associated With Anti–Programmed Death 1 (PD-1) Antibodies
- (2017) Justin C. Kao et al. JAMA Neurology
- Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature
- (2016) L. Spain et al. ANNALS OF ONCOLOGY
- Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm
- (2016) C.L. Haddox et al. ANNALS OF ONCOLOGY
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- (2016) A. M. Menzies et al. ANNALS OF ONCOLOGY
- Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain–Barré syndrome: a case report
- (2016) Ryota Tanaka et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy
- (2016) Marie-Florence de Maleissye et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer
- (2016) Tanya J. Williams et al. JAMA Neurology
- Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody
- (2016) Mehmet Asim Bilen et al. Journal for ImmunoTherapy of Cancer
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started